Authors: Janinis, J Papadakou, M Panagos, G Panousaki, A Georgoulias, V Hatzidaki, D Lefantzis, D Dokianakis, G

Citation: J. Janinis et al., Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracilin patients with locally advanced head and neck cancer, AM J CL ONC, 24(3), 2001, pp. 227-231

Authors: Janinis, J Panagos, G

Citation: J. Janinis et G. Panagos, Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer, J CL ONCOL, 18(6), 2000, pp. 1393-1394

Authors: Janinis, J Papadakou, M Xidakis, E Boukis, H Poulis, A Panagos, G Lefantzis, D

Citation: J. Janinis et al., Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer - A phase II feasibility study, AM J CL ONC, 23(2), 2000, pp. 128-131

Authors: Van Cutsem, E Cunningham, D Huinink, WWT Punt, CJA Alexopoulos, CG Dirix, L Symann, M Blijham, GH Cholet, P Fillet, G Van Groeningen, C Vannetzel, JM Levi, F Panagos, G Unger, C Wils, J Cote, C Blanc, C Herait, P Bleiberg, H

Citation: E. Van Cutsem et al., Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU), EUR J CANC, 35(1), 1999, pp. 54-59

Authors: Kouroussis, C Xydakis, E Potamianou, A Giannakakis, T Kakolyris, S Agelaki, S Sara, E Malamos, N Alexopoulos, A Mavroudis, D Samonis, G Papadouris, S Georgoulias, V Panagos, G

Citation: C. Kouroussis et al., Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study, ANN ONCOL, 10(5), 1999, pp. 547-552